Physician profile
Anne G W Peled
NPI 1336373414
$570,026.19
in general payments reported to CMS, 2019-2025
31 companies · $51K in 2025
The $51K reported for 2025 was more than what 98% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87K · 2020: $68K · 2021: $116K · 2022: $99K · 2023: $90K · 2024: $59K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $100K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $27K · Food and Beverage: $14K · Travel and Lodging: $14K · Honoraria: $500 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $99,773.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $45,429.05 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $26,550.00 |
| Food and Beverage | $14,190.41 |
| Travel and Lodging | $13,805.30 |
| Honoraria | $500.00 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $155,587.64 | 2019-2025 | Molli, Dermacell, Neptune |
| Axogen | $116,073.56 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Sientra, INC. | $94,624.81 | 2019-2023 | Sientra High Strength Cohesive Silicone Gel Breast Implant |
| Allergan, INC. | $78,978.54 | 2019-2022 | |
| Abbvie INC. | $44,588.52 | 2023-2025 | |
| Endomagnetics Ltd | $16,783.49 | 2019-2024 | Magtrace, Magseed |
| Medtronic USA, INC. | $13,377.44 | 2019 | |
| Leica Microsystems INC. | $9,230.10 | 2019-2023 | |
| Hologic INC | $8,977.26 | 2019-2023 | Biozorb |
| Merit Medical Systems INC | $6,943.63 | 2019 | |
| Gen-Probe, INC. | $6,123.97 | 2023 | Localizer |
| Motiva USA, LLC | $4,662.47 | 2024-2025 | |
| Focal Therapeutics, INC. | $4,339.65 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $1,879.50 | 2021 | |
| Tela Bio, INC. | $1,583.29 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,200.00 | 2019 | |
| Kci USA, INC. | $904.10 | 2019 | |
| Carl Zeiss Meditec, INC. | $801.98 | 2020 | |
| Myriad Genetic Laboratories, INC. | $593.37 | 2023-2024 | Myrisk |
| Bimini Technologies LLC | $500.00 | 2025 | |
| Becton, Dickinson and Company | $481.17 | 2024-2025 | Galaflex |
| Tepha INC | $432.73 | 2019 | |
| Integra Lifesciences Corporation | $346.01 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Hologic Sales and Service, LLC | $263.78 | 2023-2024 | Magseed, Magtrace, Trunode |
| Davol INC. | $201.58 | 2021-2022 | |
| Rti Surgical, INC | $187.02 | 2021-2023 | |
| Musculoskeletal Transplant Foundation INC. | $114.42 | 2025 | |
| Seagen INC. | $107.08 | 2021 | |
| Endo Pharmaceuticals INC. | $60.28 | 2019 | |
| Ricoh USA, INC. | $50.00 | 2024 | Ricoh For Healthcare Anatomic Model |
| Vertex Pharmaceuticals Incorporated | $28.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Peled listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.